Moreover, the correlation of CXCL10 with immune checkpoint blockade (ICB)-related genes has been reported not only in breast cancer but also consistently across 32 other malignancies, including DLBCL (44), highlighting its broad involvement in tumor immune regulation. This evidence concerns the gene CXCL10 and diffuse large B-cell lymphoma.